Results 41 to 50 of about 201,059 (326)
The article presents a modern view on the problem of pulmonary interstitial glycogenosis, describes a typical clinical and morphological picture of the disease, and considers the disease etiology and the possibility of pulmonary interstitial glycogenosis
O.L. Logvinova, M.A. Gonchar
doaj +1 more source
Introduction: Bronchopulmonary dysplasia (BPD) is a life-threatening lung illness that affects premature infants and has a high incidence and mortality.
Ziyu Tao +9 more
doaj +1 more source
Genetic variation in CRHR1 is associated with short-term respiratory response to corticosteroids in preterm infants at risk for bronchopulmonary dysplasia. [PDF]
BackgroundBronchopulmonary dysplasia (BPD) is an orphan disease and advances in prevention and treatment are lacking. The clinical efficacy of systemic corticosteroid therapy to reduce the severity of lung disease and BPD is highly variable.
Ballard, Philip L +5 more
core +1 more source
OBJECTIVE: To assess pulmonary function and the prevalence of atopy in school-age children who were very low birth weight as infants and to compare those who had bronchopulmonary dysplasia to those who did not.
Hercília Guimarães +5 more
doaj +1 more source
Pulmonary hypertension in the child with bronchopulmonary dysplasia
Bronchopulmonary dysplasia (BPD) is the most common chronic lung disease of prematurity resulting from complex interactions of perinatal factors that often lead to prolonged respiratory support and increased pulmonary morbidity.
K. W. Malloy, E. Austin
semanticscholar +1 more source
Bronchopulmonary dysplasia – a new perspective on prevention and treatment
Introduction Premature birth is one of the most common problems in neonatal care and affects from 6 to 14% of pregnancies (frequency depends on geographical factors) [1]. Prematurity is the cause of almost half of deaths of children younger than 5
Aleksandra Grabarczyk +8 more
doaj +1 more source
RATIONALE Bronchopulmonary dysplasia (BPD) is a heterogenous condition with poorly characterized disease subgroups. OBJECTIVES To define the frequency of three disease components: moderate-severe parenchymal disease, pulmonary hypertension (PH), or ...
Katherine Wu +9 more
semanticscholar +1 more source
Surfactant status and respiratory outcome in premature infants receiving late surfactant treatment. [PDF]
BACKGROUND:Many premature infants with respiratory failure are deficient in surfactant, but the relationship to occurrence of bronchopulmonary dysplasia (BPD) is uncertain.
A Bhandari +45 more
core +1 more source
Bronchopulmonary dysplasia [PDF]
OBJECTIVE: To review the literature on bronchopulmonary dysplasia. METHODS: The most important articles on bronchopulmonary dysplasia were selected through MEDLINE. RESULTS: The present review analyzes the different concepts, pathogenesis, clinical presentation, treatment and prophylaxis of bronchopulmonary dysplasia.
openaire +2 more sources
Excessive gas exchange impairment during exercise in a subject with a history of bronchopulmonary dysplasia and high altitude pulmonary edema [PDF]
A 27-year-old male subject (V(O2 max)), 92% predicted) with a history of bronchopulmonary dysplasia (BPD) and a clinically documented case of high altitude pulmonary edema (HAPE) was examined at rest and during exercise.
Andrew T. Lovering +6 more
core +1 more source

